| HBLAX | MACVX | HBLAX / MACVX | |
| Total Expense Ratio | 0.89 | 1.58 | 56% |
| Annual Report Gross Expense Ratio | 0.89 | 1.58 | 56% |
| Fund Existence | 20 years | 24 years | - |
| Gain YTD | 3.532 | 2.990 | 118% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 1000 | 200% |
| Min. Initial Investment IRA | 2000 | 250 | 800% |
| Net Assets | 11.1B | 3.58B | 310% |
| Annual Yield % from dividends | 3.19 | 2.41 | 132% |
| Returns for 1 year | 5.35 | 4.61 | 116% |
| Returns for 3 years | 20.20 | 15.75 | 128% |
| Returns for 5 years | 6.20 | 4.17 | 148% |
| Returns for 10 years | 42.33 | 37.98 | 111% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IMEGX | 28.87 | N/A | N/A |
| Nomura Systematic Emerging Markets Eq R6 | |||
| CEIIX | 13.77 | N/A | N/A |
| Manning & Napier Callodine Equity Inc I | |||
| CYPSX | 56.26 | N/A | N/A |
| ProFunds Consumer Disctnry Ultra Sec Svc | |||
| LMGRX | 73.93 | N/A | N/A |
| ClearBridge International Growth R | |||
| MXYKX | 4.94 | N/A | N/A |
| Empower T. Rowe Price Mid Cp Gr Instl | |||